Micell Technologies, PNNL expand research collaboration

Aug. 10, 2006 – Micell Technologies announced an expansion of its license agreement for using supercritical fluids for creating medical device surface modifications with Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle.

Under the expansion of the agreement, research will focus on additional applications of the e-RESS technology for creating drug-eluting coatings for cardiovascular stents.

The e-RESS (e for electrostatic, RESS for Rapid Expansion from Supercritical Solution) innovation involves electrostatic capture and deposition of micro and nanoparticles onto the surface of a medical device using supercritical fluids. The e-RESS technology has been exclusively licensed to Micell from PNNL, and all product developed through this expanded agreement will be licensed to Micell under the terms of the current agreement.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.